nbi 27914 has been researched along with lidocaine in 1 studies
Studies (nbi 27914) | Trials (nbi 27914) | Recent Studies (post-2010) (nbi 27914) | Studies (lidocaine) | Trials (lidocaine) | Recent Studies (post-2010) (lidocaine) |
---|---|---|---|---|---|
76 | 0 | 29 | 26,090 | 5,904 | 5,591 |
Protein | Taxonomy | nbi 27914 (IC50) | lidocaine (IC50) |
---|---|---|---|
Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonci, A; Hahn, J; Hopf, FW | 1 |
1 other study(ies) available for nbi 27914 and lidocaine
Article | Year |
---|---|
Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons.
Topics: Analysis of Variance; Anesthetics, Local; Aniline Compounds; Animals; Biophysics; Cocaine; Corticotropin-Releasing Hormone; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Lidocaine; Male; Mice; Mice, Inbred C57BL; Neurons; Patch-Clamp Techniques; Pyrimidines; Time Factors; Ventral Tegmental Area | 2009 |